Crispr Therapeutics shares owned by Citadel Advisors
Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Citadel Advisors
from 13F filings
Historical chart of Citadel Advisors investment in Crispr Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Crispr Therapeutics held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Crispr Therapeutics by Citadel Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $70M | 1.5M | 46.98 |
| 2024-06-30 | $66M | 1.2M | 54.01 |
| 2024-03-31 | $106M | 1.6M | 68.16 |
| 2023-12-31 | $133M | 2.1M | 62.60 |
| 2023-09-30 | $37M | 803k | 45.39 |
| 2023-06-30 | $47M | 836k | 56.14 |
| 2023-03-31 | $28M | 621k | 45.23 |
| 2022-12-31 | $43M | 1.0M | 40.65 |
| 2022-06-30 | $85M | 1.4M | 60.79 |
| 2022-03-31 | $73M | 1.2M | 62.77 |
| 2021-12-31 | $76M | 999k | 75.78 |
| 2021-09-30 | $110M | 983k | 111.90 |
| 2021-06-30 | $145M | 894k | 161.89 |
| 2021-03-31 | $121M | 990k | 121.85 |
| 2020-12-31 | $89M | 579k | 153.11 |
| 2020-09-30 | $18M | 214k | 83.65 |
| 2020-06-30 | $18M | 242k | 73.51 |
| 2020-03-31 | $8.4M | 199k | 42.42 |
| 2019-12-31 | $23M | 383k | 60.92 |
| 2019-09-30 | $5.8M | 142k | 40.99 |
| 2019-06-30 | $6.6M | 141k | 47.10 |
| 2019-03-31 | $4.4M | 123k | 35.73 |
| 2018-12-31 | $6.1M | 213k | 28.57 |
| 2018-09-30 | $7.1M | 160k | 44.34 |
| 2018-06-30 | $16M | 264k | 58.76 |
| 2018-03-31 | $7.1M | 156k | 45.71 |
| 2017-12-31 | $935k | 40k | 23.49 |